Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-11-01
|
| Series: | EClinicalMedicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537021004843 |
| _version_ | 1828956249616547840 |
|---|---|
| author | Vinicius Fontanesi Blum, MD, MSc Sérgio Cimerman, MD, PhD James R Hunter, PhD Paulo Tierno, MD Acioly Lacerda Alexandre Soeiro, MD Florentino Cardoso, MD Nancy Cristina Bellei, PhD, MD Juliana Maricato, PhD Nathalia Mantovani, PhD Marcella Vassao, MSc Danilo Dias Juliana Galinskas Luis Mário Ramos Janini, MD, PhD Joanna Reis Santos-Oliveira, PhD Alda Maria Da-Cruz, MD, PhD Ricardo Sobhie Diaz, MD, PhD |
| author_facet | Vinicius Fontanesi Blum, MD, MSc Sérgio Cimerman, MD, PhD James R Hunter, PhD Paulo Tierno, MD Acioly Lacerda Alexandre Soeiro, MD Florentino Cardoso, MD Nancy Cristina Bellei, PhD, MD Juliana Maricato, PhD Nathalia Mantovani, PhD Marcella Vassao, MSc Danilo Dias Juliana Galinskas Luis Mário Ramos Janini, MD, PhD Joanna Reis Santos-Oliveira, PhD Alda Maria Da-Cruz, MD, PhD Ricardo Sobhie Diaz, MD, PhD |
| author_sort | Vinicius Fontanesi Blum, MD, MSc |
| collection | DOAJ |
| first_indexed | 2024-12-14T08:06:44Z |
| format | Article |
| id | doaj.art-3db21fa89b734dc4a519f9cfbdb17eb7 |
| institution | Directory Open Access Journal |
| issn | 2589-5370 |
| language | English |
| last_indexed | 2024-12-14T08:06:44Z |
| publishDate | 2021-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EClinicalMedicine |
| spelling | doaj.art-3db21fa89b734dc4a519f9cfbdb17eb72022-12-21T23:10:09ZengElsevierEClinicalMedicine2589-53702021-11-0141101203Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]Vinicius Fontanesi Blum, MD, MSc0Sérgio Cimerman, MD, PhD1James R Hunter, PhD2Paulo Tierno, MD3Acioly Lacerda4Alexandre Soeiro, MD5Florentino Cardoso, MD6Nancy Cristina Bellei, PhD, MD7Juliana Maricato, PhD8Nathalia Mantovani, PhD9Marcella Vassao, MSc10Danilo Dias11Juliana Galinskas12Luis Mário Ramos Janini, MD, PhD13Joanna Reis Santos-Oliveira, PhD14Alda Maria Da-Cruz, MD, PhD15Ricardo Sobhie Diaz, MD, PhD16Federal University of São Paulo, São Paulo, BrazilInstituto de Infectologia Emilio Ribas, São Paulo, BrazilFederal University of São Paulo, São Paulo, BrazilHospital Municipal Dr. Francisco Moran (Barueri)SPDM (Guarulhos)INCOR and Beneficência Portuguesa, São Paulo, BrazilHospital Vera Cruz (Campinas)Federal University of São Paulo, São Paulo, BrazilFederal University of São Paulo, São Paulo, BrazilFederal University of São Paulo, São Paulo, BrazilFederal University of São Paulo, São Paulo, BrazilFederal University of São Paulo, São Paulo, BrazilFederal University of São Paulo, São Paulo, BrazilFederal University of São Paulo, São Paulo, BrazilInstituto Federal de Educação, Ciência e Tecnologia do Rio de Janeiro, IFRJ, Rio de Janeiro, BrasilInstituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro, Brazil (Laboratório Interdisciplinar de Pesquisa Médicas, Instituto Oswaldo Cruz (FIOCRUZ)Federal University of São Paulo, São Paulo, Brazil; Corresponding author: Professor Ricardo Sobhie Diaz, Federal University of Sao Paulo, Pedro de Toledo 669, 04039032 Sao Paulo, SP, Brazil, Phone: +55-11991090445, Fax: +55-1150844262http://www.sciencedirect.com/science/article/pii/S2589537021004843 |
| spellingShingle | Vinicius Fontanesi Blum, MD, MSc Sérgio Cimerman, MD, PhD James R Hunter, PhD Paulo Tierno, MD Acioly Lacerda Alexandre Soeiro, MD Florentino Cardoso, MD Nancy Cristina Bellei, PhD, MD Juliana Maricato, PhD Nathalia Mantovani, PhD Marcella Vassao, MSc Danilo Dias Juliana Galinskas Luis Mário Ramos Janini, MD, PhD Joanna Reis Santos-Oliveira, PhD Alda Maria Da-Cruz, MD, PhD Ricardo Sobhie Diaz, MD, PhD Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] EClinicalMedicine |
| title | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
| title_full | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
| title_fullStr | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
| title_full_unstemmed | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
| title_short | Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] |
| title_sort | corrigendum to nitazoxanide superiority to placebo to treat moderate covid 19 a pilot prove of concept randomized double blind clinical trial eclinicalmedicine 37 2021 100981 |
| url | http://www.sciencedirect.com/science/article/pii/S2589537021004843 |
| work_keys_str_mv | AT viniciusfontanesiblummdmsc corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT sergiocimermanmdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT jamesrhunterphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT paulotiernomd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT aciolylacerda corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT alexandresoeiromd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT florentinocardosomd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT nancycristinabelleiphdmd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT julianamaricatophd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT nathaliamantovaniphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT marcellavassaomsc corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT danilodias corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT julianagalinskas corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT luismarioramosjaninimdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT joannareissantosoliveiraphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT aldamariadacruzmdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 AT ricardosobhiediazmdphd corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981 |